Cell Impact Ab Stock Fundamentals
| CI Stock | 0.17 0.01 5.56% |
Cell Impact AB fundamentals help investors to digest information that contributes to Cell Impact's financial success or failures. It also enables traders to predict the movement of Cell Stock. The fundamental analysis module provides a way to measure Cell Impact's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cell Impact stock.
Cell |
Cell Impact AB Company Operating Margin Analysis
Cell Impact's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Cell Impact Operating Margin | (1.19) % |
Most of Cell Impact's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cell Impact AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Cell Impact AB has an Operating Margin of -1.1932%. This is much lower than that of the sector and significantly lower than that of the Operating Margin industry. The operating margin for all Sweden stocks is notably higher than that of the company.
Cell Impact AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cell Impact's current stock value. Our valuation model uses many indicators to compare Cell Impact value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cell Impact competition to find correlations between indicators driving Cell Impact's intrinsic value. More Info.Cell Impact AB is number one stock in return on equity category among its peers. It is rated fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cell Impact's earnings, one of the primary drivers of an investment's value.Cell Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cell Impact's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cell Impact could also be used in its relative valuation, which is a method of valuing Cell Impact by comparing valuation metrics of similar companies.Cell Impact is currently under evaluation in operating margin category among its peers.
Cell Fundamentals
| Return On Equity | -0.41 | |||
| Return On Asset | -0.2 | |||
| Profit Margin | (1.22) % | |||
| Operating Margin | (1.19) % | |||
| Current Valuation | 821.62 M | |||
| Shares Outstanding | 75.83 M | |||
| Shares Owned By Insiders | 17.07 % | |||
| Shares Owned By Institutions | 13.68 % | |||
| Price To Book | 2.79 X | |||
| Price To Sales | 11.09 X | |||
| Revenue | 71.35 M | |||
| Gross Profit | 34.88 M | |||
| EBITDA | (67.85 M) | |||
| Net Income | (79.85 M) | |||
| Book Value Per Share | 4.66 X | |||
| Cash Flow From Operations | (86.08 M) | |||
| Earnings Per Share | (1.41) X | |||
| Number Of Employees | 113 | |||
| Beta | 1.46 | |||
| Market Capitalization | 912.57 M | |||
| Total Asset | 238.72 M | |||
| Net Asset | 238.72 M |
About Cell Impact Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cell Impact AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cell Impact using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cell Impact AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cell Stock Analysis
When running Cell Impact's price analysis, check to measure Cell Impact's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cell Impact is operating at the current time. Most of Cell Impact's value examination focuses on studying past and present price action to predict the probability of Cell Impact's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cell Impact's price. Additionally, you may evaluate how the addition of Cell Impact to your portfolios can decrease your overall portfolio volatility.